INVO Fertility, Inc. (IVF)Healthcare | Medical Devices | Sarasota, United States | NasdaqCM
2.28 USD
+0.18
(8.571%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:51 p.m. EDT
IVF is in terminal decline with a negative forecast model predicting a nearly 28% drop over 45 days, exacerbated by failed growth, massive debt exposure, and a history of confusing reverse stock splits indicating capital erosion. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.639987 |
| MSTL | 0.929440 |
| AutoETS | 0.953828 |
| AutoARIMA | 1.012283 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 3.85 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.820 |
| Excess Kurtosis | 0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 72.39 |
| Revenue per Share | 252.717 |
| Market Cap | 15,871,296 |
| Forward P/E | -0.10 |
| Previous Name | NAYA Biosciences |
| Website | https://www.invobioscience.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.98944443 |
| Address1 | 5,582 Broadcast Court |
| All Time High | 440,723.06 |
| All Time Low | 1.92 |
| Ask | 2.66 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 47,310 |
| Average Daily Volume3 Month | 342,147 |
| Average Volume | 342,147 |
| Average Volume10Days | 47,310 |
| Bid | 1.64 |
| Bid Size | 2 |
| Book Value | -22.336 |
| City | Sarasota |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.28 |
| Current Ratio | 0.123 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.29 |
| Day Low | 2.06 |
| Debt To Equity | 72.39 |
| Display Name | INVO Fertility |
| Dividend Date | 1,604,880,000 |
| Earnings Timestamp End | 1,755,518,400 |
| Earnings Timestamp Start | 1,754,996,340 |
| Ebitda | -7,119,142 |
| Ebitda Margins | -1.0252401 |
| Enterprise To Ebitda | -1.913 |
| Enterprise To Revenue | 1.961 |
| Enterprise Value | 13,617,784 |
| Eps Forward | -23.2 |
| Eps Trailing Twelve Months | -1,474.4 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.7503 |
| Fifty Day Average Change | -1.4703 |
| Fifty Day Average Change Percent | -0.39204863 |
| Fifty Two Week Change Percent | -98.94444 |
| Fifty Two Week High | 384.0 |
| Fifty Two Week High Change | -381.72 |
| Fifty Two Week High Change Percent | -0.9940625 |
| Fifty Two Week Low | 1.92 |
| Fifty Two Week Low Change | 0.36 |
| Fifty Two Week Low Change Percent | 0.18750001 |
| Fifty Two Week Range | 1.92 - 384.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,604,327,400,000 |
| Float Shares | 349,691 |
| Forward Eps | -23.2 |
| Forward P E | -0.098275855 |
| Free Cashflow | 950,669 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 33 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.39174 |
| Gross Profits | 2,720,199 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01043 |
| Held Percent Institutions | 0.16459998 |
| Implied Shares Outstanding | 6,961,095 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Last Split Date | 1,774,569,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida. |
| Long Name | INVO Fertility, Inc. |
| Market | us_market |
| Market Cap | 15,871,296 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1859772254 |
| Most Recent Quarter | 1,759,190,400 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -11,220,118 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 3,174,259 |
| Number Of Analyst Opinions | 1 |
| Open | 2.09 |
| Operating Cashflow | -7,657,071 |
| Operating Margins | -0.93079 |
| Payout Ratio | 0.0 |
| Phone | 978 878 9505 |
| Pre Market Change | -0.06040001 |
| Pre Market Change Percent | -2.6491232 |
| Pre Market Price | 2.2196 |
| Pre Market Time | 1,776,775,901 |
| Prev Name | NAYA Biosciences |
| Previous Close | 2.1 |
| Price Hint | 4 |
| Price To Book | -0.10207736 |
| Price To Sales Trailing12 Months | 2.2856462 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.068 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.18 |
| Regular Market Change Percent | 8.57143 |
| Regular Market Day High | 2.29 |
| Regular Market Day Low | 2.06 |
| Regular Market Day Range | 2.06 - 2.29 |
| Regular Market Open | 2.09 |
| Regular Market Previous Close | 2.1 |
| Regular Market Price | 2.28 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 38,918 |
| Return On Assets | -0.48356998 |
| Revenue Growth | 0.226 |
| Revenue Per Share | 252.717 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 6,961,095 |
| Shares Percent Shares Out | 0.056799997 |
| Shares Short | 79,020 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 106,618 |
| Short Name | INVO Fertility, Inc. |
| Short Percent Of Float | 0.056799997 |
| Short Ratio | 1.2 |
| Source Interval | 15 |
| State | FL |
| Symbol | IVF |
| Target High Price | 20.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 20.0 |
| Target Median Price | 20.0 |
| Total Cash | 355,891 |
| Total Cash Per Share | 0.941 |
| Total Debt | 4,233,890 |
| Total Revenue | 6,943,899 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1,474.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 26.62285 |
| Two Hundred Day Average Change | -24.34285 |
| Two Hundred Day Average Change Percent | -0.9143593 |
| Type Disp | Equity |
| Volume | 38,918 |
| Website | https://www.invobioscience.com |
| Zip | 34,240 |